Alterations to PRKACB function through gene fusion are mutually exclusive from GNAS mutation in biliary tract cancer [61] and either mutually exclusive in pancreatic cancer [89] or not completely mutually exclusive [38]. This evidence concerns the gene PRKACB and familial pancreatic carcinoma.